Influence of the angiotensin II type 1 receptor gene polymorphism on the effects of perindopril and nitrendipine on arterial stiffness in hypertensive individuals.
about
Genetic basis of cardiovascular disease--the renin-angiotensin-aldosterone system as a paradigmGenetic determinants of arterial stiffness.Advances in pharmacogenetics and pharmacogenomics.Promoter Polymorphism of RGS2 Gene Is Associated with Change of Blood Pressure in Subjects with Antihypertensive Treatment: The Azelnidipine and Temocapril in Hypertensive Patients with Type 2 Diabetes Study.Pharmacogenetics: an opportunity for a safer and more efficient pharmacotherapy.Genetic variations in human G protein-coupled receptors: implications for drug therapy.Angiotensin II receptor polymorphisms in hypertension. Pharmacogenomic considerations.Clinical applications of arterial stiffness: therapeutics and pharmacology.Arterial stiffness: a brief review.Keeping pace with ACE: are ACE inhibitors and angiotensin II type 1 receptor antagonists potential doping agents?Pharmacogenomics: the future of drug therapy.Cardiovascular pharmacogenomics: current status, future prospects.Effect of antihypertensive agents on arterial stiffness as evaluated by pulse wave velocity: clinical implications.Angiotensin receptor blockade in the challenging era of systolic hypertension.Polymorphism in angiotensin II receptor genes and hypertension.The genetic basis for altered blood vessel function in disease: large artery stiffeningPharmacogenetic interactions of three candidate gene polymorphisms with ACE-inhibitors or beta-blockers and the risk of atherosclerosis.Gene markers and antihypertensive therapy.The G protein-coupled receptors: pharmacogenetics and disease.Impact of GPCRs in clinical medicine: monogenic diseases, genetic variants and drug targetsAgeing and vascular ageing.Polymorphism in the angiotensin II type 1 receptor (AGTR1) is associated with age at diagnosis in pulmonary arterial hypertensionGenetics and pathophysiology of arterial stiffness.Mechanical properties of normal and diseased cerebrovascular system.Aortic correlates of clinical markers of large artery structure and function. Effects of aging and hypertension.Effect of NR3C2 genetic polymorphisms on the blood pressure response to enalapril treatment.Arterial stiffness and the renin-angiotensin-aldosterone system.Arg347Cys polymorphism of alpha1A-adrenoceptor gene is associated with blood pressure response to nifedipine GITS in Chinese hypertensive patients.Recruitment of participants through community pharmacies for a pharmacogenetic study of antihypertensive drug treatment.Genetic determination of plasma aldosterone levels in essential hypertension.Strategies for Achieving Healthy Vascular Aging.Influence of the Angiotensin II type I receptor gene 1166A > C polymorphism on BP and aortic pulse wave velocity among Malays.Interaction between polymorphisms in the renin–angiotensin–system and angiotensin-converting enzyme inhibitor or β-blocker use and the risk of myocardial infarction and stroke
P2860
Q28215488-885585A1-9132-4D01-B354-3EABAE9AB172Q30301168-A31323EE-315A-4039-B416-644113826901Q34024117-D6515395-08C0-4C1F-8078-E72424FED74EQ34218218-A8C11648-B586-4F81-833D-217B57B38716Q34368342-866632B2-D5D9-489F-9F6E-5174AFCFF8E4Q34461998-76F0F2D5-8D2E-4F2B-BECC-3FC0E231372EQ34609146-F1CD43C7-4A2D-49B5-85E9-82CA3EDA4A99Q34647819-59EED0A3-A2DB-4771-B877-DE2BC962B54DQ34807187-CB26FAD1-B5EE-4156-9445-238AC3CBF85BQ34886182-A10336CE-1C6C-4E5A-9112-8D20127B2FCEQ34952587-E794F1AC-D6DD-40A0-B4FC-67CCFC5F732AQ35090469-7BE66CBD-6D0C-4691-86C7-29A6D416159CQ35631306-06850044-A198-427B-ABA0-499F2DC06CC5Q35866273-0864C0E4-E367-4CA3-A8BA-1BD3BA7FF906Q36003958-4472494A-356A-4095-8955-45F1A464E273Q36012883-B1BAFA26-365B-4896-BA51-0CB4D0EB48B5Q36024528-B2CCDF4C-AF60-4E40-B16D-06959415FB6FQ36025918-1BF38B00-EC57-46C3-991F-F4FA8F4865DDQ36310854-4657044E-8427-4F68-950C-D3B976C4FD3BQ36316001-DB73ED74-1DC8-421A-BB3A-7ABAE8B3E8FCQ36497741-ED4B9DFB-5CD4-4C12-8AE8-629D77CC6BB6Q37015627-FB9E7833-BA3C-4EDC-8CC1-45E57A559558Q37355473-3109FB30-8E93-48EB-B561-BEB0980EF4AFQ38003989-9837C6A3-2272-4853-BAA0-485264476768Q40260465-7E0742DA-C41A-4811-BF3F-6B84DCDDFA0FQ45124856-46BC85B7-B595-4032-AE08-DD5CCDC11121Q45139058-B9D59CE0-2A00-4884-AF1F-744061CB6948Q45292671-B33E7F7B-C514-4068-AF0F-2DCC3AD56656Q46179673-82585D02-4B4B-4078-9872-8CD75C9B644CQ47771186-96ACD88E-9128-49EE-B688-F219C4F01C6DQ50133565-2C69BFA2-4E3B-46BD-B3BB-C6637A7837EDQ54561955-84423A07-B77A-4E5B-9987-EF164F08B189Q57781843-41C39007-C062-49F7-98DB-658533F047B5
P2860
Influence of the angiotensin II type 1 receptor gene polymorphism on the effects of perindopril and nitrendipine on arterial stiffness in hypertensive individuals.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Influence of the angiotensin I ...... s in hypertensive individuals.
@en
Influence of the angiotensin I ...... s in hypertensive individuals.
@nl
type
label
Influence of the angiotensin I ...... s in hypertensive individuals.
@en
Influence of the angiotensin I ...... s in hypertensive individuals.
@nl
prefLabel
Influence of the angiotensin I ...... s in hypertensive individuals.
@en
Influence of the angiotensin I ...... s in hypertensive individuals.
@nl
P2093
P356
P1433
P1476
Influence of the angiotensin I ...... s in hypertensive individuals.
@en
P2093
J Topouchian
P Lacolley
P304
P356
10.1161/01.HYP.28.6.1081
P407
P577
1996-12-01T00:00:00Z